These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1083298)

  • 41. A new perspective on B cell triggering: control of the immune response by organizational changes in the lipid bilayer.
    Barton MA; Diener E
    Transplant Rev; 1975; 23():5-22. PubMed ID: 49106
    [No Abstract]   [Full Text] [Related]  

  • 42. Macrophage requirements of CR- and CR+ B lymphocytes for antibody production in vitro.
    Hoffmann MK; Hämmerling U; Simon M; Oettgen HF
    J Immunol; 1976 May; 116(5):1447-51. PubMed ID: 1083874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti B and T cell activity of antiserum to spleen cells of athymic (nu/nu) mice: evidence for surface antigenic differences between functionally distinct subclasses of T and B lymphocytes.
    Kisielow P; Shiku H
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):671-88. PubMed ID: 63275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective activation of T lymphocytes. Its possible application in the immunomanipulation of tumours.
    Miller JF
    Biomedicine; 1973 Mar; 18(2):81-5. PubMed ID: 4199988
    [No Abstract]   [Full Text] [Related]  

  • 45. Separation of cells according to surface antigens by the use of antibody-coated columns. Fractionation of cells carrying immunoglobulins and blood group antigen.
    Wigzell H; Sundqvist KG; Yoshida TO
    Scand J Immunol; 1972; 1(1):75-87. PubMed ID: 4627539
    [No Abstract]   [Full Text] [Related]  

  • 46. A population of lymphocytes bearing a membrane receptor antigen-antibody-complement complexes. II. Specific isolation.
    Eden A; Bianco C; Nussenzweig V
    Cell Immunol; 1971 Dec; 2(6):658-69. PubMed ID: 5317411
    [No Abstract]   [Full Text] [Related]  

  • 47. Functionally active C1 on the surface of human peripheral lymphocytes: its role in the complement-mediated inhibition of the Fc receptor of B lymphocytes.
    Füst G; Erdei A; Sármay G; Medgyesi GA; Gergely J
    Clin Immunol Immunopathol; 1976 May; 5(3):377-87. PubMed ID: 776475
    [No Abstract]   [Full Text] [Related]  

  • 48. Lymphoid cell interactions in cell-mediated immunity.
    Dennert G; Lennox ES
    Adv Exp Med Biol; 1973; 29(0):157-66. PubMed ID: 4546858
    [No Abstract]   [Full Text] [Related]  

  • 49. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 50. Factors affecting the propagation of a B cell clone forming antibody to the 2,4-dinitrophenyl group.
    Askonas BA; Williamson AR
    Eur J Immunol; 1972 Dec; 2(6):487-93. PubMed ID: 4120275
    [No Abstract]   [Full Text] [Related]  

  • 51. Functional significance of the Fc receptor on mixed lymphocyte culture-activated T blasts.
    Hayry P; Andersson LC
    Cell Immunol; 1976 Aug; 25(2):237-44. PubMed ID: 133765
    [No Abstract]   [Full Text] [Related]  

  • 52. Surface markers of small lymphocytes appearing in the mouse Ehrlich ascites tumour, host spleen and blood.
    Garnis S; Lala PK
    Immunology; 1978 Mar; 34(3):487-99. PubMed ID: 640717
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surface markers of B and T cells. Recent technical developments reveal a heterogeneity of lymphocyte subpopulations.
    Ross GD
    Arch Pathol Lab Med; 1977 Jul; 101(7):337-41. PubMed ID: 326222
    [No Abstract]   [Full Text] [Related]  

  • 54. Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells.
    Herberman RB; Nunn ME; Holden HT
    J Immunol; 1978 Jul; 121(1):304-9. PubMed ID: 307576
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics.
    Jondal M; Wigzell H; Aiuti F
    Transplant Rev; 1973; 16():163-95. PubMed ID: 4272900
    [No Abstract]   [Full Text] [Related]  

  • 56. Autoreactivity developing spontaneously in cultured mouse spleen cells. II. Comparison of cytotoxicity of cultured male and female spleen cells.
    Gorczynski RM
    Immunology; 1976 Oct; 31(4):615-23. PubMed ID: 789230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lymphocyte stimulation with Fc fragments. II. Requirement for mature B lymphocytes.
    Berman MA; Morgan EL; Weigle WO
    Cell Immunol; 1980 Jul; 52(2):341-9. PubMed ID: 6969124
    [No Abstract]   [Full Text] [Related]  

  • 58. Trypanosome-mediated suppression of murine humoral immunity independent of typical suppressor cells.
    Albright JW; Albright JF
    J Immunol; 1980 May; 124(5):2481-4. PubMed ID: 6444974
    [No Abstract]   [Full Text] [Related]  

  • 59. The thymus origin of the carrier-specific cell in an anti-hapten response in vitro.
    Trowbridge IS; Anderson HR
    Eur J Immunol; 1972 Dec; 2(6):565-70. PubMed ID: 4540163
    [No Abstract]   [Full Text] [Related]  

  • 60. ACA-1, a new differentiation antigen of activated lymphoid cells.
    Nesterenko VG; Novikova TK; Fontalin LN; Rubakova EI; Gruner S; Wechnik E; Sidorova EV
    Cell Immunol; 1983 Jul; 79(2):253-64. PubMed ID: 6223705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.